Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.
Partner Content Partner Content What oncologists need from you when launching a new therapy At the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is no surprise that two-years on, the number of therapeutic options in cancer care is growin
Partner Content Partner Content Abbvie and Astrazeneca to present keynote address’ at SMi’s ... Drug Discovery conference 2018
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
